IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2004 by Nantes University Hospital.
Recruitment status was: Active, not recruiting
Recruitment status was: Active, not recruiting
Sponsor:
Nantes University Hospital
Information provided by:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT00200603
First received: September 9, 2005
Last updated: December 15, 2005
Last verified: May 2004
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to compare radiological behavior of blocks of macroporous phosphocalcium as bone substitute in comparison with iliac crest autograft in tibial valgus osteotomy.
| Condition | Intervention |
|---|---|
| Osteoarthritis of the Knee | Device: calcium phosphate macroporous bioceramics |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy |
Resource links provided by NLM:
MedlinePlus related topics:
Calcium
Drug Information available for:
Calcium Gluconate
U.S. FDA Resources
Further study details as provided by Nantes University Hospital:
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- knee osteoarthritis eligible for tibial valgus osteotomy
- > 18 y.o
Exclusion Criteria:
- prior tibial osteotomy
- history of local infection
- rheumatoid and other inflammatory arthritis
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00200603
Please refer to this study by its ClinicalTrials.gov identifier: NCT00200603
Locations
| France | |
| Gouin François | |
| Nantes, France, 44093 | |
Sponsors and Collaborators
Nantes University Hospital
Investigators
| Principal Investigator: | François Gouin, MD | Nantes UH |
More Information
| ClinicalTrials.gov Identifier: | NCT00200603 History of Changes |
| Other Study ID Numbers: |
BRD/99/3-G |
| Study First Received: | September 9, 2005 |
| Last Updated: | December 15, 2005 |
Keywords provided by Nantes University Hospital:
|
Calcium phosphate ceramic tibial osteotomy osteoarthritis |
Additional relevant MeSH terms:
|
Osteoarthritis Osteoarthritis, Knee Arthritis Joint Diseases Musculoskeletal Diseases |
Rheumatic Diseases Calcium, Dietary Bone Density Conservation Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on June 23, 2017